New Key Statistics Module, Z-Score and F-Score
NAS:MCRB Key Ratios
| Market Cap $ M | 132.11 |
| Enterprise Value $ M | 273.50 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 435.35 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -1.18 |
| Beneish M-Score | 739.92 |
| 10-y EBITDA Growth Rate % | -5.50 |
| 5-y EBITDA Growth Rate % | 10.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.87 |
| EV-to-EBITDA | -1.96 |
| PEG | -- |
| Shares Outstanding M | 151.73 |
| Net Margin (%) | -43,343.58 |
| Operating Margin % | -42,211.23 |
| Pre-tax Margin (%) | -43,343.58 |
| Quick Ratio | 0.89 |
| Current Ratio | 1.38 |
| ROA % (ttm) | -45.14 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -86.37 |
| Dividend Yield % | -- |
| Altman Z-Score | -5.72 |
MCRB Number of Guru Trades
MCRB Volume of Guru Trades
Gurus Latest Trades with NAS:MCRB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:MCRB is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Seres Therapeutics Inc Insider Transactions
No Available Data
News about NAS:MCRB
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers